News & Analysis on Clinical Trial Services & Contract Research And Development
South Korea's Samsung Group has announced plans to form a 'strategic partnership' with US contract research organisation (CRO), Quintiles, as it gears up to enter the biopharma market.
LG Life Sciences is to build an influenza vaccine production facility in South Korea after licensing technology from Novavax.
Generic drugmaker SOHM has expanded its manufacturing capacity for “lifestyle” diseases to meet growing Indian demand.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Kendle, Selcia and ERT.
New research has questioned the widely accepted $1.3bn average cost of R&D per new drug, claiming it is an overestimate and an obstacle.
Frontage Laboratories has achieved AAALAC accreditation at its Pennsylvania, US animal research facility.
Four US packaging firms have merged to form Aphena Pharma Solutions in a bid to create a single-source offering.
Contract packagers will lose deals if they fail to adapt to biopharm outsourcing “more and more” serialisation work, according to CEO of Covectra.